Moneycontrol PRO
HomeNewsIndiaCovid-19 surge in India: Active cases rise to 4,026; five deaths reported in 24 hours

Covid-19 surge in India: Active cases rise to 4,026; five deaths reported in 24 hours

The fatalities were recorded in Kerala, Maharashtra, Tamil Nadu, and West Bengal, all involving patients with underlying health conditions.

June 03, 2025 / 09:34 IST
India’s active COVID-19 caseload has increased to 4,026, with five more deaths reported in the last 24 hours (as of 8 am, Tuesday).

India’s active COVID-19 caseload has increased to 4,026, with five more deaths reported in the last 24 hours (as of 8 am, Tuesday), according to the Ministry of Health and Family Welfare. The fatalities were recorded in Kerala, Maharashtra, Tamil Nadu, and West Bengal, all involving patients with underlying health conditions.

Kerala reported the death of an 80-year-old man with severe pneumonia and acute respiratory distress syndrome (ARDS), in addition to diabetes, hypertension, and coronary artery disease. Maharashtra recorded two deaths - a 70-year-old woman with diabetes and another 73-year-old woman with both diabetes and hypertension.

In Tamil Nadu, a 69-year-old woman with Type 2 diabetes and Parkinson’s disease succumbed to the virus. West Bengal reported the death of a 43-year-old woman who was suffering from acute coronary syndrome, septic shock, and acute kidney injury.

The latest wave is being attributed to the highly transmissible NB.1.8.1 sub-variant, a descendant of the Omicron lineage.

The Indian Council of Medical Research (ICMR) has confirmed that although the new strain spreads rapidly and is highly mutable, it continues to cause mild illness. Common symptoms include fever, cough, sore throat, fatigue, headache, body aches, runny nose, and loss of appetite - similar to seasonal flu.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Despite the growing caseload, health authorities have urged the public not to panic. Both central and state governments have ramped up precautionary measures. Hospitals across the country are on high alert, with preparations including the review of bed availability and the stocking up of oxygen cylinders and other emergency resources.

Union Minister of State for Health and AYUSH, Prataprao Jadhav, reassured that the Centre is “fully prepared” to respond to any COVID-related emergencies. He said that health infrastructure built during previous waves, such as oxygen generation plants and ICU beds, has been reviewed and reinforced as part of contingency planning.

Meanwhile, the Delhi High Court, on Monday, raised concerns over delays in establishing formal protocols for COVID-19 sample collection and transportation. The observation came during a hearing of a contempt petition filed by Dr. Rohit Jain, who alleged that authorities failed to comply with a January 27, 2023, court order directing the government to set minimum standards in this regard.

Justice Girish Kathpalia noted that although a meeting chaired by the Additional Director General of Health Services was held on May 30, 2023, resulting in the formation of four sub-committees to draft the Standard Operating Procedures (SOPs), there has been no clarity on outcomes. The court directed the Centre’s counsel, Monika Arora, to submit a detailed status report within six weeks. The next hearing is scheduled for July 18.

Moneycontrol News
first published: Jun 3, 2025 09:03 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347